De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor
Abstract N-methyl-d-aspartate receptors (NMDARs) are members of the glutamate receptor family and participate in excitatory postsynaptic transmission throughout the central nervous system. Genetic variants in GRIN genes encoding NMDAR subunits are associated with a spectrum of neurological disorders. The M3 transmembrane helices of the NMDAR couple directly to the agonist-binding domains and form a helical bundle crossing in the closed receptors that occludes the pore. The M3 functions as a transduction element whose conformational change couples ligand binding to opening of an ion conducting pore. In this study, we report the functional consequences of 48 de novo missense variants in GRIN1, GRIN2A, and GRIN2B that alter residues in the M3 transmembrane helix. These de novo variants were identified in children with neurological and neuropsychiatric disorders including epilepsy, developmental delay, intellectual disability, hypotonia and attention deficit hyperactivity disorder. All 48 variants in M3 for which comprehensive testing was completed produce a gain-of-function (28/48) compared to loss-of-function (9/48); 11 variants had an indeterminant phenotype. This supports the idea that a key structural feature of the M3 gate exists to stabilize the closed state so that agonist binding can drive channel opening. Given that most M3 variants enhance channel gating, we assessed the potency of FDA-approved NMDAR channel blockers on these variant receptors. These data provide new insight into the structure–function relationship of the NMDAR gate, and suggest that variants within the M3 transmembrane helix produce a gain-of-function..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:81 |
|---|---|
| Enthalten in: |
Cellular and molecular life sciences - 81(2024), 1 vom: 28. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Xu, Yuchen [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| BKL: | |
|---|---|
| Themen: |
Channelopathy |
| Anmerkungen: |
© The Author(s) 2024 |
|---|
| doi: |
10.1007/s00018-023-05069-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR055314201 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR055314201 | ||
| 003 | DE-627 | ||
| 005 | 20240328072108.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240328s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00018-023-05069-z |2 doi | |
| 035 | |a (DE-627)SPR055314201 | ||
| 035 | |a (SPR)s00018-023-05069-z-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 570 |a 610 |q VZ |
| 084 | |a 42.15 |2 bkl | ||
| 100 | 1 | |a Xu, Yuchen |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s) 2024 | ||
| 520 | |a Abstract N-methyl-d-aspartate receptors (NMDARs) are members of the glutamate receptor family and participate in excitatory postsynaptic transmission throughout the central nervous system. Genetic variants in GRIN genes encoding NMDAR subunits are associated with a spectrum of neurological disorders. The M3 transmembrane helices of the NMDAR couple directly to the agonist-binding domains and form a helical bundle crossing in the closed receptors that occludes the pore. The M3 functions as a transduction element whose conformational change couples ligand binding to opening of an ion conducting pore. In this study, we report the functional consequences of 48 de novo missense variants in GRIN1, GRIN2A, and GRIN2B that alter residues in the M3 transmembrane helix. These de novo variants were identified in children with neurological and neuropsychiatric disorders including epilepsy, developmental delay, intellectual disability, hypotonia and attention deficit hyperactivity disorder. All 48 variants in M3 for which comprehensive testing was completed produce a gain-of-function (28/48) compared to loss-of-function (9/48); 11 variants had an indeterminant phenotype. This supports the idea that a key structural feature of the M3 gate exists to stabilize the closed state so that agonist binding can drive channel opening. Given that most M3 variants enhance channel gating, we assessed the potency of FDA-approved NMDAR channel blockers on these variant receptors. These data provide new insight into the structure–function relationship of the NMDAR gate, and suggest that variants within the M3 transmembrane helix produce a gain-of-function. | ||
| 650 | 4 | |a Glutamate receptor |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a NMDA receptor |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a TMD |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Channelopathy |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Functional genomics |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Song, Rui |4 aut | |
| 700 | 1 | |a Perszyk, Riley E. |4 aut | |
| 700 | 1 | |a Chen, Wenjuan |4 aut | |
| 700 | 1 | |a Kim, Sukhan |4 aut | |
| 700 | 1 | |a Park, Kristen L. |0 (orcid)0000-0001-5527-3047 |4 aut | |
| 700 | 1 | |a Allen, James P. |4 aut | |
| 700 | 1 | |a Nocilla, Kelsey A. |4 aut | |
| 700 | 1 | |a Zhang, Jing |4 aut | |
| 700 | 1 | |a XiangWei, Wenshu |4 aut | |
| 700 | 1 | |a Tankovic, Anel |4 aut | |
| 700 | 1 | |a McDaniels, Ellington D. |4 aut | |
| 700 | 1 | |a Sheikh, Rehan |4 aut | |
| 700 | 1 | |a Mizu, Ruth K. |4 aut | |
| 700 | 1 | |a Karamchandani, Manish M. |4 aut | |
| 700 | 1 | |a Hu, Chun |4 aut | |
| 700 | 1 | |a Kusumoto, Hirofumi |4 aut | |
| 700 | 1 | |a Pecha, Joseph |4 aut | |
| 700 | 1 | |a Cappuccio, Gerarda |4 aut | |
| 700 | 1 | |a Gaitanis, John |4 aut | |
| 700 | 1 | |a Sullivan, Jennifer |4 aut | |
| 700 | 1 | |a Shashi, Vandana |4 aut | |
| 700 | 1 | |a Petrovski, Slave |4 aut | |
| 700 | 1 | |a Jauss, Robin-Tobias |4 aut | |
| 700 | 1 | |a Lee, Hyun Kyung |4 aut | |
| 700 | 1 | |a Bozarth, Xiuhua |4 aut | |
| 700 | 1 | |a Lynch, David R. |4 aut | |
| 700 | 1 | |a Helbig, Ingo |4 aut | |
| 700 | 1 | |a Pierson, Tyler Mark |4 aut | |
| 700 | 1 | |a Boerkoel, Cornelius F. |4 aut | |
| 700 | 1 | |a Myers, Scott J. |4 aut | |
| 700 | 1 | |a Lemke, Johannes R. |4 aut | |
| 700 | 1 | |a Benke, Timothy A. |4 aut | |
| 700 | 1 | |a Yuan, Hongjie |0 (orcid)0000-0002-8127-7145 |4 aut | |
| 700 | 1 | |a Traynelis, Stephen F. |0 (orcid)0000-0002-3750-9615 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cellular and molecular life sciences |d Springer International Publishing, 1997 |g 81(2024), 1 vom: 28. März |w (DE-627)SPR00008039X |w (DE-600)1458497-9 |x 1420-9071 |7 nnns |
| 773 | 1 | 8 | |g volume:81 |g year:2024 |g number:1 |g day:28 |g month:03 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00018-023-05069-z |z kostenfrei |3 Volltext |
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 42.15 |q VZ |
| 951 | |a AR | ||
| 952 | |d 81 |j 2024 |e 1 |b 28 |c 03 | ||